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Telomeres are regions of tandem arrays of TTAGGG repeats and associated proteins located at
chromosomal ends that allow cells to distinguish chromosome ends from double-strand breaks
and protect chromosomes from end-to-end fusion, recombination, and degradation (Houben et al.,
2008). Telomeres are not linear structures, telomeric DNA is maintained in a loop structure due to
many key proteins. This structure serves to protect the ends of chromosomes (Neidle and Parkin-
son, 2003). Telomeres are subjected to shortening at each cycle of cell division due to incomplete
synthesis of the lagging strand during DNA replication owing to the inability of DNA polymerase
to completely replicate the ends of chromosome DNA (“end-replication problem”) (Muraki et al.,
2012). Therefore, they assume to limit the number of cell cycles and act as a “mitotic clock”
(Olovnikov, 1996). Shortened telomeres cause decreased proliferative potential, thus triggering
senescence (Blackburn et al., 2006).
Telomere length (TL) is highly heterogeneous in somatic cells, but generally decreases with
age in proliferating tissues thereby constituting a barrier to tumorigenesis but also contributing
to age-related loss of stem cells. Repair of critically short (“uncapped”) telomeres by telomerase
enzyme, which elongates chromosomal ends by synthesizing new telomeric repeats, is limited in
somatic cells, and cellular senescence, apoptosis and/or a permanent cell cycle arrest in G1 phase
are triggered by a critical accumulation of uncapped telomeres (D’Souza et al., 2013). Telomerase
maintains TL by adding telomeric DNA repeats to chromosome ends in prenatal tissues, gametes,
stem cells, and cancerous cells. In proliferative somatic cells, it is usually inactive or expressed
at levels that are not high enough to maintain the stable TL (Hiyama and Hiyama, 2007). Alter-
native lengthening of telomeres (ALT) pathway is a recombination-mediated process, which can
increase telomere length by thousands of base-pairs within a few somatic cell cycles (Liu et al.,
2007). Telomere-initiated cellular senescence is a mechanism of eliminating cells with damaged
DNA and protection against cancerogenesis (through the activation mechanisms of cell cycle arrest
or double-strand breaks-induced apoptosis), but it may also impair the cell function contributing to
degenerative organ failure and organismal aging (Chen et al., 2007; Campisi, 2013). Cellular senes-
cence (a state of irreversible cell cycle arrest) occurring in response to a telomere shortening may be
regulated by immune surveillance. In this process, senescent cells interact with their environment
by secreting various growth factors and cytokines, being thereby recognized and eliminated by an
antigen-specific immune response (Hoenicke and Zender, 2012; Sagiv and Krizhanovsky, 2013).
Shortened telomeres have also been observed in a variety of chronic degenerative diseases, includ-
ing type 2 diabetes, cardiovascular disease, osteoporosis, and cancer (Armanios, 2013; Babizhayev
et al., 2014). The specific molecular mechanism by which short telomeres trigger the development
of diseases is, however, not yet determined. It has been proposed that telomere shortening per-
se might not be a direct signal for cell cycle arrest, but rather the consequence of telomere loss
(Vaziri and Benchimol, 1996). It can promote a pro-inflammatory secretory phenotype, in turn
contributing to a variety of age-related diseases.
Replicative attrition, however, is not the only explanation for age-dependent telomere short-
ening. Some studies demonstrate that this process can be non-replicative and significantly stress-
dependent because of the deficiency of a telomere-specific damage repair (von Zglinicki, 2003).
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Potential stochastic nature of progressive telomere shortening
was shown by Levy et al. (1992). Accumulating research find-
ings suggest that psychophysiological stress may accelerate the
telomere attrition from early development, and maybe even pre-
natally, with potential impact for life-long health (Shalev et al.,
2013a; Monaghan, 2014). For example, it has been shown that
the more violence children had experienced the shorter were
their telomeres from 5 to 10 years of age (Shalev et al., 2013b).
In the study by Entringer et al. (2011), young adults whose
mothers were exposed to severe stressors during pregnancy (for
example, due to the death of a close family member) had more
short telomeres than those subjects whose mothers had a rel-
atively stress-free pregnancy. Several studies also indicate that
effects of exposure to stress early in life may persist into adult-
hood. In research by Surtees et al. (2011), it has been demon-
strated that the more adversity women had experienced during
their childhood the shorter were their telomeres in adult life.
By investigating the hypothesis that psychophysiological stress
may impact health by modulating the rate of cellular aging, Epel
et al. (2004) examined the TLs and telomerase activity levels
in mothers of healthy or chronically sick children. The second
group was predicted to be more chronically stressed than the
first one. In this research, mothers of ill children demonstrated
substantially reduced telomerase activity which was equivalent
to the 9–17 years of additional cellular aging as compared to
those women who had healthy children, and rates of cellular
aging were obviously associated with levels of stress exposure.
Substantial telomere attrition was also revealed among caregivers
of AD (Alzheimer’s disease) patients. In this occupational group,
telomere shortening was clearly associated with symptoms of
depression, in comparison to control subjects matched for gen-
der and age (Damjanovic et al., 2007). The correlation between
level of perceived stress and TL was clearly confirmed in a recent
meta-analysis conducted by Schutte and Malouff (2014).
Oxidative stress is one of the most important stress factors
causing telomere shortening (Houben et al., 2008; Zhang et al.,
2014). Telomeric DNA is known to be more susceptible to oxida-
tive damage than non-telomeric DNA, owing to the high con-
tent of guanine residues and a reduced DNA repair capacity in
telomeric regions (Gomes et al., 2010). Triple guanine repeats of
telomeric DNA were shown to be particularly prone to oxidative
damage, and they may generate oxidatively modified bases such
as 8-oxoguanine which is the main substrate for the base excision
repair (BER) pathway (Kawanishi and Oikawa, 2004).Wang et al.
(2010) demonstrated that oxidative damage of guanine plays an
important role in disruption of telomere integrity and presumes
that BER pathway is substantially involved in repair of oxida-
tive base lesions in mammalian telomeres. Moreover, telomeric
DNA, in contrast to genomic DNA, is deficient in repair of single
strand breaks and double strand breaks, and telomere dysfunc-
tion is believed to mediate the effect of oxidative base damage to
abnormal nuclear morphology (Coluzzi et al., 2014). In human
cell lines, telomeres generally shorten by 30–200 base pairs at each
round of DNA replication, but only approximately 10 base pairs
of this reduction are a consequence of the end-replication prob-
lem; the remaining loss is likely owing to oxidative damage (Mon-
aghan and Haussmann, 2006). Systemic chronic inflammation to
accelerate aging via ROS-mediated telomere dysfunction and cell
senescence was shown in mice (Jurk et al., 2014).
In several studies, it was found, that DNA damaging agents
cause telomere erosion, primarily, by high levels of reactive oxy-
gen species (ROS) regardless of age of the cell donor. For exam-
ple, in the Richter and von Zglinicki (2007) study, high levels of
oxidative stress cause accelerated rates of telomere erosion and,
ultimately, arrest of the cell cycle in cell cultures derived from
donors of various ages (embryonic to adult). Moreover, it was
revealed that over-expression of superoxide dismutase in a cell
line with low antioxidant capacity slowed erosion of telomeres
(Serra et al., 2003). Further evidence for non-replicative cause
of telomere shortening comes from the fact that the telomere
erosion rate varies in a stochastic manner among cells in fibrob-
last clones, derived from single cells, thereby causing sub-clonal
heterogeneity in replicative lifespan (Martin-Ruiz et al., 2004).
Recently, it was found that such cell-to-cell heterogeneity may
come from stochastic heterogeneity in oxidative DNA damage
caused, e.g., by variations in the cell’s metabolic processes (Snijder
and Pelkmans, 2011; Trusina, 2014). Another pathway for non-
replicative telomere erosion relates to non-canonical function of
telomerase, mainly, protection of mitochondria against oxidative
stress (Saretzki, 2014). The fact that TERT is transported out of
the nucleus under long-term low level oxidative stress suggests
that protection of mitochondrial DNAmight have higher priority
than protection of telomeres maintenance under stress (Ahmed
et al., 2008).
The complexity of processes underlying age-related telom-
ere erosion came from several longitudinal studies of telomere
dynamics in vivo. Research of TLs in blood cells of snakes, birds,
and humans unexpectedly revealed, that no TLs changes with
aging were found (for review, see Eisenberg, 2011). Moreover, the
faster age-related decline in leukocyte TLs was observed among
subjects with longer telomeres at baseline early-adult examina-
tions, suggesting that longer telomeres provide bigger amount of
targets for oxidative stress-related telomere erosion (Aviv et al.,
2009). Traditionally, it was assumed that telomeres are stable
structures, which may be changed only in unidirectional way—
shortening over the lifetime. Today, however, it has become
increasingly clear that telomeres shortening over time in an oscil-
latory rather than linear fashion and theymay be either shortened
or lengthened under certain conditions (Epel, 2012). Several pilot
studies indicate that treatment procedures targeting to reduce
stress, e.g., meditation, along with the enhanced physical activity
and changes in dietary patterns, can slow or even reverse telom-
ere shortening owing to the elevated telomerase activity (Jacobs
et al., 2011; Blackburn and Epel, 2012). The elongation of telom-
eres may be caused by the telomerase-mediated extension or
appear due to the “pseudo-telomeric lengthening.” The latest is
due to the fact that, since TLs are commonly measured in amixed
leukocyte population, mean TL can increase because of a redis-
tribution of cell subpopulations, i.e., change in the percentage of
various cell types in the blood samples.
Consistent evidence suggest that telomere erosion may be a
common mechanism that triggers all major processes underlying
aging, includingmutation accumulation, mitochondrial dysfunc-
tion and stem cell failure (Armanios, 2013), as well as epigenetic
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changes likely through silencing of gene expression by forma-
tion of long-range chromatin interactions (Fojtová and Fajkus,
2014; Misteli, 2014). Induction of senescence occurs in reac-
tion to a critically short telomere length and to the triggering of
DNA damage response. Therefore, unraveling the factors caus-
ing telomere attrition may be important for further progress in
understanding the basic mechanisms of aging. In this context, it
is particularly important to establish the relative significance of
end-replication and oxidative damage events in the age-related
telomere erosion.
Given data from recent studies, a concept that replicative
senescence is a “clocked” and stepwise process seems doubtful,
and repeatedly reported reproducibility of both replicative lifes-
pans and rates of telomere shortening could be the result of
stochastic rather than programmed events (von Zglinicki, 2003).
In other words, it seems that telomeres can be an indicator
of stress-induced damage level rather than a mitosis “counter.”
Moreover, considering the fact that oxidative stress represents
a common causative mechanism for both age-related telom-
ere shortening (Houben et al., 2008) and age-associated dis-
ease (Richardson and Schadt, 2014), there are reasons to believe
that relationships between TL and morbidity or mortality are
non-causal, and TL can be an indicator of previous exposure
to oxidative stress that may, in turn, cause both greater telom-
ere shortening and higher risk of chronic disease. Thereby, per-
ceived stressful events, though correlated with TL, may likely
have independent effects on health and longevity (Eisenberg,
2011). By summarizing recent research findings, Trusina (2014)
conclude that recently obtained knowledge “shift the telom-
ere paradigm from a simple clock counting cell divisions to
a more complex process recording the history of stress expo-
sure within a cell lineage.” This point of view, based on the
accumulated evidence, appears plausible, and requires further
investigation.
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